Brief: Absci And Owkin Partner To Advance Generative AI Drug Discovery
Jan 10 (Reuters) - Absci Corp ABSI.O :
* ABSCI AND OWKIN SYNERGIZE LEADING TECHBIO PLATFORMS TO
ADVANCE
GENERATIVE AI DRUG DISCOVERY
Source text: urn:newsml:reuters.com:*:nGNX62Dc5Y
Further company coverage: ABSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AbSci
See all newsAbsci Corp reports results for the quarter ended September 30 - Earnings Summary
Brief: Absci Corp Files For Mixed Shelf Size Not Disclosed - SEC Filing
Absci Q3 revenue misses estimates, net loss widens on R&D spends
Focus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave